Development of A Novel Adult Stem Cell-based Drug Discovery Platform at Mayo Clinic
Biobusiness Grant Recipient: Dennis Wigle, MD, PhD
Grant Period: 2016-2017
Award Value: $98,846
Site: Mayo Clinic
Using the extensive biobank of human induced pluripotent stem cells (n > 250) housed within the Mayo Clinic Center for Regenerative Medicine Biotrust, our goal is to develop a technical platform for the screening of novel drugs as well as drug libraries. By capitalizing on this extensive, stem cell-based resource, we aim to develop novel therapeutic options for Minnesota's patient population.